The effects of mTOR inhibition in ischemic stroke
With a global incidence of 9.5 million cases annually and 56 million disability-adjusted life-years, ischemic stroke is the primary cause of adult disability in developed countries. However, the significant successes in stroke trials have been in the field of reperfusion therapies for ischemic strok...
| Príomhchruthaitheoir: | |
|---|---|
| Rannpháirtithe: | |
| Formáid: | Tráchtas |
| Teanga: | English |
| Foilsithe / Cruthaithe: |
2022
|
| Ábhair: |